Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A prospective phase I/II, one-arm, one-stage multi-center, open label study of lenalidomide in combination with pioglitazone, dexamethasone and metronomic low-dose chemotherapy with treosulfan in patients with relapsed or refractory or progressive multiple myeloma: Third-line therapy https://kusajili.com:443/Trial/_yK5BhgsP0C46cXF1k5D7Q%24a-prospective-phase-iii-one-arm-one-stage-multi-center-open-label-study-of-lenalidomide-in-combination-with-pioglitazone-dexame
I have read and accept the terms of use of the site and the Privacy Policy
Send your message